JBS (JBS) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
13 Jan, 2026Executive summary
Q3 2024 delivered record net revenue of $19.9 billion, up 6.4% year-over-year, with adjusted EBITDA of $2.2 billion and net profit of $693 million.
Achieved global leadership in beef and poultry, with diversified operations across the Americas, Europe, and Australia, and over 270,000 team members worldwide.
Free cash flow for the quarter was $994 million, up 65% year-over-year; leverage improved to 2.15x, with net debt down to $13.7 billion.
Dividends totaling $1.2 billion announced for 2024, with $812 million paid in October and $382 million to be paid in January 2025; share buyback program reopened.
Continued investment in innovation, sustainability, and expansion, including new facilities and product lines.
Financial highlights
Net sales reached $19.9 billion (+6.4% y/y); adjusted EBITDA was $2.2 billion (+94.3% y/y, margin 10.8%); net profit $693 million.
Gross profit increased to $3.28 billion, with gross margin improving to 16.5% from 12.1% year-over-year.
Free cash flow generation was strong across all business units except JBS Beef North America.
CapEx for the quarter was $321 million, with 60% for maintenance and 40% for expansion.
Dividend yield stands at approximately 8.5%.
Outlook and guidance
2024 guidance: net revenue expected at $77 billion, adjusted EBITDA between $6.9–$7.1 billion, implying a 9–9.3% margin.
Focus on diversification, innovation, value-added products, and sustainability initiatives.
Leverage expected to fall below 2x by year-end if current trends continue.
Latest events from JBS
- Global protein leader with $91.2B revenue, rising margins, and strong global diversification.JBS
Institutional presentation - Record sales and improved cash flow offset by margin pressure and a net loss in 2Q26.JBS
Q2 2026 - Sustainable growth, margin expansion, and global diversification drive strong returns.JBS
Investor Day 2026 presentation - Global protein leader with $88.3B revenue, margin growth, and expanding global footprint.JBS
Investor presentation - Global protein leader with $88.3B revenue, expanding through diversification and strategic investment.JBS
Investor presentation - Net sales up 11% to $21.6B–$22B, but EBITDA and net income declined; leverage at 2.77x.JBS
Q1 2026 - Record $86.2B revenue and $2.02B net income in 2025, with margin pressure in North America.JBS
Q4 2025 - Q2 2024 saw record margins, $329M net profit, and strong cash flow, led by poultry and pork.JBS
Q2 2024 - Record revenue, margin expansion, and lower leverage highlight robust 2024 performance.JBS
Q4 2024